2025-09-04 - Analysis Report
Okay, here's an analysis of UnitedHealth Group Inc (UNH) based on the data provided, presented as a concise report in English:

## UnitedHealth Group Inc (UNH) Stock Analysis

**Company Overview:** UnitedHealth Group Inc (UNH) is a diversified healthcare company providing a wide range of health benefits and services.

### 1. Performance vs. S&P 500 (VOO)

*   **UNH Cumulative Return:** 17.08%
*   **VOO Cumulative Return:** 99.17%
*   **Absolute Divergence:** -86.5%
*   **Relative Divergence:** 9.5%

**Analysis:** UNH has significantly underperformed the S&P 500 (VOO) over the analyzed period. The relative divergence indicates UNH's performance is near the lower end of its historical range compared to the S&P 500.

**Alpha, Beta Analysis**

| Year       | CAGR   | MDD    | Alpha  | Beta   | Cap(B) |
|------------|--------|--------|--------|--------|--------|
| 2015-2017  | 65.0%  | 56.6%  | 36.0%  | 0.0    | 199.7  |
| 2016-2018  | 52.0%  | 63.7%  | 34.0%  | 0.0    | 225.7  |
| 2017-2019  | 38.0%  | 63.7%  | 9.0%   | 0.3    | 266.3  |
| 2018-2020  | -21.0% | 63.7%  | -40.0% | 0.4    | 317.6  |
| 2019-2021  | 36.0%  | 61.0%  | -13.0% | 0.4    | 454.8  |
| 2020-2022  | 28.0%  | 66.9%  | 26.0%  | 0.4    | 480.2  |
| 2021-2023  | 33.0%  | 67.5%  | 15.0%  | 0.4    | 476.9  |
| 2022-2024  | -31.0% | 68.6%  | -57.0% | 0.3    | 458.2  |
| 2023-2025  | -59.0% | 75.7%  | -110.0%| 0.1    | 276.5  |

**Analysis:**

*   **CAGR and MDD:** The table shows the Compound Annual Growth Rate (CAGR) and Maximum Drawdown (MDD) for rolling three-year periods. The CAGR has varied significantly, with some periods showing strong growth and others showing substantial losses. The MDD indicates the maximum peak-to-trough decline during each period, highlighting the volatility in UNH's returns.
*   **Alpha and Beta:**
    *   **Alpha:** The alpha values fluctuate widely, indicating that UNH's performance relative to its benchmark has varied significantly over time. The negative alpha values in recent periods (e.g., -57.0% and -110.0%) suggest underperformance compared to the benchmark.
    *   **Beta:** The beta values are relatively low, suggesting that UNH's price movements are not strongly correlated with the broader market. The beta values close to 0 in earlier periods (2015-2018) indicate minimal market sensitivity, while the slightly higher betas in later periods (0.3-0.4) suggest a moderate level of correlation.
*   **Market Cap:** The market capitalization (Cap) of UNH has seen significant growth over the years, peaking in 2020-2022 before declining in the more recent periods.

### 2. Recent Stock Price Movements

*   **Current Price:** 305.25
*   **Last Market Data:**
    *   Price: 305.285
    *   Previous Close: 308.8
    *   Change: -1.14
*   **5-day Moving Average:** 304.344
*   **20-day Moving Average:** 285.1755
*   **60-day Moving Average:** 291.445

**Analysis:**  The current price is slightly below the previous close, indicating a recent dip. The 5-day moving average is near the current price. The price is above both the 20-day and 60-day moving averages, which suggests an upward trend over the past 20-60 days despite the recent dip.

### 3. Indicators and Signals

*   **Market Risk Indicator (MRI):** 0.3403 (Low Risk)
*   **RSI:** 74.81 (Overbought)
*   **PPO:** 0.9779
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (2 shares - Caution - MRI:0.34) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-09-02)
*   **Recent (20-day) Relative Divergence Change:** -2.3 (Negative - Short-term Decline)
*   **Expected Return:** 79.8% (Long-term, relative to S&P 500)
*   **Price change:** -1.14

**Analysis:**

*   **MRI:** The low MRI suggests low overall market risk.
*   **RSI:** The RSI is in overbought territory, indicating a potential pullback.
*   **PPO:** The PPO is positive, indicating a bullish trend.
*   **Hybrid Signal:** The signal suggests buying a portion of available cash (80%) with caution.
*   **Recent Divergence Change:** The negative change in relative divergence suggests short-term underperformance compared to the S&P 500.
*   **Price change:** It represents a slight decline, however, it is not significant to trigger a sharp downturn

### 4. Recent News & Significant Events

*   **[2025-09-04]:** Business developments, regulatory changes, or market events.
*   **[2025-09-03]:** Analyst discussion of performance and outlook.
*   **[2025-09-01]:** Notable stock volatility.
*   **[2025-08-31]:** Highlighted risks and opportunities, recommending monitoring of news.

**Analysis:**  The news indicates UNH is experiencing significant activity, including volatility and analyst scrutiny.  Investors should monitor news and company announcements.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출          |
|------------|------|---------------|
| 2025-08-11 | 3.76 | 111.62 B$     |
| 2025-05-07 | 6.9  | 109.58 B$     |
| 2024-11-04 | 6.56 | 100.82 B$     |
| 2024-08-09 | 4.58 | 98.86 B$      |
| 2025-08-11 | 4.58 | 98.86 B$      |

**Analysis:** Revenue and EPS data show that UnitedHealth Group has been consistently generating substantial revenue and profits. However, there is some variability in the quarterly EPS figures. The revenue has generally been increasing, with the latest quarter showing the highest revenue figure.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue     | Profit Margin |
|--------------|-------------|---------------|
| 2025-06-30   | $111.62B    | 17.93%        |
| 2025-03-31   | $109.58B    | 21.70%        |
| 2024-12-31   | $100.81B    | 21.14%        |
| 2024-09-30   | $100.82B    | 22.84%        |
| 2024-06-30   | $98.86B     | 22.31%        |

**Capital and Profitability:**

| Quarter      | Equity      | ROE       |
|--------------|-------------|-----------|
| 2025-06-30   | $94.72B    | 3.60%     |
| 2025-03-31   | $95.04B    | 6.62%     |
| 2024-12-31   | $92.66B    | 5.98%     |
| 2024-09-30   | $94.53B    | 6.41%     |
| 2024-06-30   | $89.36B    | 4.72%     |

**Analysis:**

*   **Revenue and Profitability:** UnitedHealth Group demonstrates strong revenue generation capabilities, with consistent growth across the quarters. However, there is a slight decrease in profit margin in the most recent quarter (2025-06-30) compared to previous quarters.
*   **Capital and Profitability:** The company has a significant equity base, which has been relatively stable over the past few quarters. The Return on Equity (ROE) has seen some fluctuations, with the highest ROE observed in the quarter ending March 31, 2025, followed by a decline in the quarter ending June 30, 2025.

### 7. Overall Summary and Conclusion

UNH has underperformed the S&P 500 recently, although long-term expectations suggest potential outperformance. The stock exhibits overbought conditions, and while recent performance has been weaker, longer-term trends are still positive. Recent news suggests the company is in a period of change and volatility. Financials show strong revenue but a recent dip in profit margin, and fluctuating ROE.
